0.03Open0.05Pre Close4 Volume3.29K Open Interest1.00Strike Price16.00Turnover212.36%IV21.35%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.3194Delta1.6253Gamma21.44Leverage Ratio-0.0076Theta0.0000Rho6.85Eff Leverage0.0004Vega
Ocugen Stock Discussion
Grabbed a few at .88. It usually hovers around $1-2, a little upside
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet